The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -45.19% this year. Over the last six months, there has been a stronger performance of -39.07%. The price of ESPR fallen by 25.96% during the last 30 days period. For the last 5-days stocks have improved 16.96%.
Esperion Therapeutics Inc (ESPR) has a current stock price of $1.31. During the previous trading session, the stock witnessed a notable rise, reaching a high of $16.0 after opening at $1.31. The stock’s low for the day was $1.5, and it eventually closed at $1.22.
Esperion Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $3.94 on 12/09/24, and the lowest price during the same period was recorded at $0.69 on 05/15/25.
52-week price history of ESPR Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Esperion Therapeutics Inc’s current trading price is -66.75% away from its 52-week high, while its distance from the 52-week low is 89.17%. The stock’s price range for this period has been between $0.69 and $3.94. The Healthcare sector company’s shares saw a trading volume of about 1.71 million for the day, which was lower than the average daily volume of 4.39 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Esperion Therapeutics Inc (ESPR) has experienced a quarterly rise of 40.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 259.64M and boasts a workforce of 304 employees.
Expert Opinions: Analysts’ Ratings for Esperion Therapeutics Inc
As of right now, 2 analysts are rating Esperion Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1616, with a change in price of -0.3750. Similarly, Esperion Therapeutics Inc recorded 4,659,175 in trading volume during the last 100 days, posting a change of -22.59%.
ESPR Stock Stochastic Average
As of today, the raw stochastic average of Esperion Therapeutics Inc over the last 50 days is at 97.53%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 95.73%. Further, the company’s Stochastic %K and %D values for the last 20 days were 80.92% and 75.64%, respectively.
